Price Matt A, Fast Patricia E, Mshai Mercy, Lambrick Maureen, Machira Yvonne Wangũi, Gieber Lisa, Chetty Paramesh, Muturi-Kioi Vincent
IAVI, New York City, New York, United States of America.
Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California, United States of America.
PLOS Glob Public Health. 2022 Nov 14;2(11):e0000783. doi: 10.1371/journal.pgph.0000783. eCollection 2022.
Region-specific laboratory reference intervals (RIs) are important for clinical trials and these data are often sparse in priority areas for research, including Africa. We reviewed data on RIs from Africa to identify gaps in the literature with a systematic review of PubMed for RI studies from Africa published ≥2010. Search focus included clinical analytic chemistry, hematology, immunological parameters and RIs. Data from adults, adolescents, children, pregnant women, and the elderly were included. We excluded manuscripts reporting data from persons with conditions that might preclude clinical trial participation in studies enrolling healthy volunteers. Of 179 identified manuscripts, 80 were included in this review, covering 20 countries with the largest number of studies in Ethiopia (n = 23, 29%). Most studies considered healthy, nonpregnant adults (n = 55, 69%). Nine (11%) studies included pregnant women, 13 (16%) included adolescents and 22 (28%) included children. Recruitment, screening, enrollment procedures and definition of age strata varied across studies. The most common type of RIs reported were hematology (66, 83%); 14 studies (18%) included flow cytometry and/or T cell counts. Other common tests or panels included liver function assays (32, 40%), renal function assays (30, 38%), lipid chemistries (17, 21%) and serum electrolytes (17, 21%). The number of parameters characterized ranged from only one (three studies characterized either CD4+ counts, D-dimer, or hemoglobin), to as many as 40. Statistical methods for calculating RIs varied. 56 (70%) studies compared their results to international RI databases. Though most presented their data side-by-side with international data with little accompanying analysis, nearly all reported deviation from comparator RI data, sometimes with half or more of otherwise healthy participants having an "out of range" result. We found there is limited local RI data available in sub-Saharan Africa. Studies to fill this gap are warranted, including efforts to standardize statistical methods to derive RIs, methods to compare with other RIs, and improve representative participant selection.
特定区域的实验室参考区间(RIs)对临床试验很重要,而在包括非洲在内的重点研究领域,这些数据往往很稀少。我们回顾了来自非洲的RIs数据,通过对PubMed中2010年及以后发表的非洲RI研究进行系统回顾,以找出文献中的差距。搜索重点包括临床分析化学、血液学、免疫参数和RIs。纳入了来自成人、青少年、儿童、孕妇和老年人的数据。我们排除了报告来自可能妨碍参与招募健康志愿者的临床试验的人群的数据的手稿。在179篇已识别的手稿中,80篇被纳入本综述,涵盖20个国家,其中埃塞俄比亚的研究数量最多(n = 23,29%)。大多数研究考虑的是健康的非孕妇成人(n = 55,69%)。9项(11%)研究纳入了孕妇,13项(16%)纳入了青少年,22项(28%)纳入了儿童。不同研究的招募、筛查、入组程序和年龄层定义各不相同。报告的最常见的RIs类型是血液学(66项,83%);14项研究(18%)包括流式细胞术和/或T细胞计数。其他常见的检测或检测组合包括肝功能检测(32项,40%)、肾功能检测(30项,38%)、脂质化学检测(17项,21%)和血清电解质检测(17项,21%)。所表征的参数数量从仅一个(三项研究分别表征了CD4+计数、D - 二聚体或血红蛋白)到多达40个不等。计算RIs的统计方法各不相同。56项(70%)研究将其结果与国际RI数据库进行了比较。尽管大多数研究将其数据与国际数据并列呈现,但几乎没有附带分析,几乎所有研究都报告了与对照RI数据的偏差,有时有一半或更多原本健康的参与者结果“超出范围”。我们发现撒哈拉以南非洲地区可用的本地RI数据有限。有必要开展研究来填补这一空白,包括努力标准化推导RIs的统计方法、与其他RIs进行比较的方法以及改进代表性参与者的选择。